A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Boston Scientific Corp stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 2,225,689 shares of BSX stock, worth $171 Million. This represents 1.57% of its overall portfolio holdings.

Number of Shares
2,225,689
Previous 1,224,301 81.79%
Holding current value
$171 Million
Previous $47.4 Million 117.23%
% of portfolio
1.57%
Previous 0.81%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$39.56 - $47.22 $39.6 Million - $47.3 Million
1,001,388 Added 81.79%
2,225,689 $103 Million
Q3 2022

Nov 07, 2022

BUY
$36.71 - $109.66 $1.13 Million - $3.38 Million
30,858 Added 2.59%
1,224,301 $47.4 Million
Q2 2022

Aug 09, 2022

BUY
$35.24 - $47.1 $37.5 Million - $50.1 Million
1,064,561 Added 826.0%
1,193,443 $44.5 Million
Q1 2022

May 13, 2022

BUY
$40.9 - $45.1 $167,362 - $184,549
4,092 Added 3.28%
128,882 $5.71 Million
Q4 2021

Feb 11, 2022

SELL
$38.07 - $44.87 $255,297 - $300,898
-6,706 Reduced 5.1%
124,790 $5.3 Million
Q3 2021

Nov 09, 2021

BUY
$41.23 - $45.88 $694,230 - $772,527
16,838 Added 14.69%
131,496 $5.71 Million
Q2 2021

Aug 16, 2021

SELL
$38.58 - $44.24 $395,483 - $453,504
-10,251 Reduced 8.21%
114,658 $4.9 Million
Q1 2021

May 14, 2021

BUY
$35.27 - $39.67 $9,064 - $10,195
257 Added 0.21%
124,909 $4.83 Million
Q4 2020

Feb 08, 2021

SELL
$33.15 - $41.97 $242,624 - $307,178
-7,319 Reduced 5.55%
124,652 $4.48 Million
Q3 2020

Nov 09, 2020

SELL
$34.44 - $42.23 $7.41 Million - $9.09 Million
-215,183 Reduced 61.98%
131,971 $5.04 Million
Q2 2020

Aug 10, 2020

BUY
$30.19 - $39.11 $10.5 Million - $13.6 Million
347,154 New
347,154 $12.2 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $110B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Rothschild & CO Asset Management Us Inc. Portfolio

Follow Rothschild & CO Asset Management Us Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.